Sign in to view content

Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME

Seenu M. Hariprasad, MD

Video
Published 2018

Related

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
Orbital Emphysema as a Complication of Vitrectomy: Report of 12 Consecutive Cases
Virgilio Morales-Canton, MD
Annual Meeting Talks
2018
Severe Vision Loss After Intravitreal Injections of Autologous Adipose Tissue-derived Stem Cells for Age-Related Macular
Ajay E Kuriyan, MD, MS
Updates from the Field
2016

Category: Diabetic Retinopathy

See more